Market Quotes Powered By Forexpros, the Forex, Futures, and Stock Markets Portal.
Positive outcome for Aerocrine in patent proceedings against Medisoft in Belgium
SOLNA, Sweden - 29 June, 2012
AB (OMX Nordic Exchange: AERO) today announced the positive outcome of
its complaint against Medisoft S.A. filed at the Liège Commercial
On 14 October 2011, Aerocrine started infringement
proceedings against the Belgian company Medisoft S.A. before the Liège
Commercial Court, on the basis of four of Aerocrine´s patents. Medisoft
challenged both infringement and the validity of the patents as part of
its defense. The oral hearings on the merits took place during the
Yesterday the Court upheld Aerocrine’s patents EP
1,439,781 and EP 1,661,514 as valid and ruled that both the Medisoft
Hyp’Air FeNO and Hyp’Air FeNO+ devices infringe these patents.
Accordingly, Medisoft which is headquartered in Belgium, will be
immediately prohibited as from service of the decision, from
manufacturing, using, maintaining, detaining and offering for sale any
The Court also invalidated Aerocrine´s
earliest patents EP 0,606,351 and EP 0,724,723 for Belgium. These
patents expire in 2012 and 2014.
The judgment may be appealed by both parties.
Based on a press release
What do you think about this article and us? Please leave a comment!